How to Buy Mimedx Group Stock
Mimedx Group Inc
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.
Mimedx Group stock last closed at $6.68, up 0.75% from the previous day, and has increased 5.53% in one year. It has overperformed other stocks in the Biotechnology industry by 0.84 percentage points. Mimedx Group stock is currently +22.12% from its 52-week low of $5.47, and -34.12% from its 52-week high of $10.14.
There are currently 147.37M MDXG shares outstanding. The market capitalization of MDXG is $984.41M. In the past 24 hours, 373,721 MDXG shares were traded.
How to Buy Mimedx Group Stock
Wondering how to invest in Mimedx Group stock? Here's how.
- Figure out where to buy Mimedx Group stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you choose where to buy Mimedx Group stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Select your payment method and add your details.
- Analyze Mimedx Group stock: The Mimedx Group ticker symbol is MDXG. Is Mimedx Group stock a good investment? Should you buy shares of MDXG? How do MDXG's underlying business fundamentals look? Do top analysts think Mimedx Group is a good buy? Why has MDXG's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if MDXG is a good stock to buy).
- Make your MDXG trade: Decide if you will purchase MDXG shares at the current market price or use a limit order to buy MDXG stock at a particular price.
- Keep an eye on your investment in MDXG: Create a watchlist to track your position in Mimedx Group shares.
Step 1: Figure out where to buy Mimedx Group stock
You need a brokerage account in order to access the NASDAQ market and buy MDXG stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal information so you are able to buy MDXG stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new brokerage account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have opened your account on apps for stocks, your next step is to transfer the money for your investment:
Check out this video walkthrough for more details depositing funds into your brokerage account.
Step 4: Analyze Mimedx Group stock
After you have selected the best place to buy Mimedx Group stock, it's very important to evaluate their stock before you invest, so you can wrap your head around the risk and upside.
Overview of key MDXG info
MDXG Due Diligence Checks
WallStreetZen was built to help average investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on MDXG's stock page.
Is MDXG stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge MDXG's true value.
Using relative valuations methods:
- MDXG could be undervalued based on its P/E ratio of 23.03x, relative to Biotechnology industry P/E ratio of -177.72x
- MDXG may be overvalued based on its P/B ratio of 5.1x, relative to Biotechnology industry P/B ratio of 4.05x
- MDXG could be undervalued based on its PEG ratio of 0.69x
You can do more valuation research on MDXG's stock here.
Is MDXG a healthy company?
Positive Health Checks:
- There are more short-term assets than long-term liabilities on the MDXG balance sheet.
- MDXG's operating cash flow of $66.20M allows it to safely service it's debt of $18.83M.
- MDXG has a low debt to equity ratio of 0.37.
- MDXG earnings of $58.72M is not sufficient to cover its interest payments.
- Total MDXG debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the MDXG balance sheet.
Negative Health Checks:
- MDXG profit margin has gone down from 18.1% to 12.2% in the past year.
Do Wall Street analysts think it's a good time to buy Mimedx Group stock
Out of 1 sell side analysts who monitor MDXG, the consensus analyst rating on MDXG is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Mimedx Group stock forecast page.
Metrics for Advanced MDXG Traders
MDXG Performance Metrics
Last year, MDXG earnings were $42.42M. In the past one years, MDXG's earnings have gone up by -27.5% per year. This was slower than the Biotechnology industry average of 10.71%.
Last year, MDXG revenue was $348.88M. Over the past five year, MDXG's revenue has gone up by 3.12% per year. This was slower than the Biotechnology industry average of 44.43%.
Learn more about MDXG's earnings and revenue performance here.
What are MDXG insiders up to?
In the past 12 months, executives and large shareholders at MDXG have sold more shares than they have bought.
William Frank Hulse Iv, General Counsel and CAO of MDXG, was the latest MDXG insider to sell. They sold $60,889.36 worth of MDXG stock on Apr 8, 2025.
Learn more about who owns MDXG stock here.
Can I get consistent income from MDXG stock?
No, Mimedx Group doesn't provide an income stream by paying out dividends.
What do other investors have to say about MDXG?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your MDXG trade
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, place a limit order.
Press the Open Trade button and your broker will execute your order.
If you need more help with investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your investment in MDXG
Now that you own some shares in MDXG, you'll want to keep up with your stock purchase.
Start a watchlist to get notified of the latest news about your MDXG stock.
MDXG Feed
How to Buy Stock in Mimedx Group
To reiterate, here are the 6 steps to buy Mimedx Group stock:
- Figure out where to buy Mimedx Group stock
- Open your brokerage account
- Fund your investment account
- Analyze Mimedx Group stock
- Make your MDXG trade
- Keep an eye on your investment in MDXG
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your new investment in Mimedx Group, add MDXG to your watchlist below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.